139 related articles for article (PubMed ID: 24495445)
1. Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans.
Qi P; Tsivian M; Abern MR; Passoni NM; McGinley KF; Polascik TJ
Urol Oncol; 2014 Jul; 32(5):555-60. PubMed ID: 24495445
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities in Histology and Short-Term Renal Functional Outcomes Following Robotic Nephron-Sparing Surgery.
Wang JC; Lai WR; Traore EJ; Liu J; Sholl AB; Mandava SH; Maddox MM; Mitchell GC; Viriyasiripong S; Silberstein JL; Kittles R; Lee BR
Clin Genitourin Cancer; 2017 Apr; 15(2):203-206. PubMed ID: 27554583
[TBL] [Abstract][Full Text] [Related]
3. Racial Comparison of Patients Undergoing Minimally Invasive Partial Nephrectomy for Renal Masses at a Large Volume Tertiary Center.
Sands KG; Bhatt R; Vetter J; Paradis A; Chow AK; Bhayani S; Figenshau RS; Venkatesh R
J Endourol; 2021 Sep; 35(9):1365-1371. PubMed ID: 33730861
[No Abstract] [Full Text] [Related]
4. Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohort.
Chen VS; Abouassaly R; Gonzalez CM; Kutikov A; Smaldone MC; Meropol NJ; Psutka SP; Williams SB; O'Malley R; Sedlacek HM; Kim SP
Urol Oncol; 2017 Nov; 35(11):662.e17-662.e21. PubMed ID: 28781110
[TBL] [Abstract][Full Text] [Related]
5. Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center.
Kara O; Andrade HS; Zargar H; Akca O; Maurice MJ; Caputo PA; Ramirez D; Malkoc E; Modlin CS; Kaouk JH
J Robot Surg; 2016 Mar; 10(1):5-10. PubMed ID: 26861450
[TBL] [Abstract][Full Text] [Related]
6. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
7. The effect of race and gender on the surgical management of the small renal mass.
Kates M; Whalen MJ; Badalato GM; McKiernan JM
Urol Oncol; 2013 Nov; 31(8):1794-9. PubMed ID: 22687567
[TBL] [Abstract][Full Text] [Related]
8. Clear Cell Papillary Renal Cell Carcinoma: New Clinical and Imaging Characteristics.
Wang K; Zarzour J; Rais-Bahrami S; Gordetsky J
Urology; 2017 May; 103():136-141. PubMed ID: 28130179
[TBL] [Abstract][Full Text] [Related]
9. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
[TBL] [Abstract][Full Text] [Related]
10. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
11. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
12. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC).
Meagher MF; Patil D; Saito K; Javier-Desloges JF; Bradshaw AW; Patel SH; Cotta BH; Yasuda Y; Eldefrawy A; Ghali F; Nasseri R; Wan F; Fujii Y; Master V; Derweesh IH
Urology; 2022 May; 163():164-176. PubMed ID: 34995562
[TBL] [Abstract][Full Text] [Related]
14. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
15. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
[TBL] [Abstract][Full Text] [Related]
17. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of oncological outcomes and perioperative complications between laparoscopic and open radical nephrectomies in patients with clinical T2 renal cell carcinoma (≥7cm).
Lee H; Lee CU; Yoo JH; Sung HH; Jeong BC; Jeon SS; Lee HM; Choi HY; Jeong CW; Kwak C; Seo SI
PLoS One; 2018; 13(1):e0191786. PubMed ID: 29364958
[TBL] [Abstract][Full Text] [Related]
19. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
[TBL] [Abstract][Full Text] [Related]
20. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
